MDA

Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia

This coverage survey was conducted as part of an ongoing monitoring strategy within the Amhara Trachoma Control Program. The Carter Center provided the Amhara Regional Health Bureau with support to implement MDA, and separately, also funded, designed and executed this survey in collaboration with the Regional Health Bureau.

Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial

The WHO recommends 3–5 years of annual mass azithromycin distribution with at least 80% treatment coverage to districts with active trachoma prevalence over 10% among children. This article assesses the efficacy of expanding the coverage target to at least 90% for trachoma control in a mesoendemic region of Niger.

Subscribe to RSS - MDA